Related Experiment Video
Updated: Jun 22, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Saporin suicide gene therapy
Natasa Zarovni1, Riccardo Vago, Maria Serena Fabbrini
1Department of Biological and Technological Research, Dibit, San Raffaele H Scientific Institute, Milano, Italy.
This study introduces a novel suicide gene therapy using plant ribosome-inactivating proteins (RIPs), specifically saporin (SAP), to trigger apoptotic cell death in tumor cells. The approach demonstrated significant tumor growth attenuation in a melanoma model, offering a cost-effective and safe therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Therapy
- Biotechnology
Background:
- Suicide gene therapy offers a promising avenue for cancer treatment by selectively eliminating tumor cells.
- Plant ribosome-inactivating proteins (RIPs) are potent toxins that inhibit protein synthesis, inducing apoptosis.
Purpose of the Study:
- To develop and evaluate a novel suicide gene therapy strategy utilizing the saporin (SAP) gene from Saponaria officinalis.
- To assess the efficacy of SAP-driven gene constructs in inhibiting protein synthesis and reducing tumor growth in a preclinical melanoma model.
Main Methods:
- Construction of plasmids expressing the mature saporin (SAP) gene under viral (CMV) and potentially tumor-specific promoters.
- In vitro testing of SAP constructs for protein synthesis inhibition in co-transfected tumor cells using a luciferase reporter gene.
- In vivo evaluation of intratumoral injections of SAP-expressing plasmid DNA (pCI-SAP) complexed with delivery agents (lipofectamine or DOTAP) in a B16 melanoma mouse model.
Main Results:
- SAP expression, driven by the CMV promoter, significantly reduced luciferase reporter activity in cultured melanoma cells.
- Intratumoral administration of pCI-SAP complexes resulted in noteworthy attenuation of tumor growth in mice.
- Repeated administrations of the DNA complexes further augmented the anti-tumor effect, demonstrating enhanced efficacy.
Conclusions:
- The saporin-based suicide gene therapy is a cost-effective and safe approach for cancer treatment.
- This strategy effectively inhibits protein synthesis and reduces tumor growth, showing potential for clinical application.
- Further development of tumor-specific promoters could enhance the targeted delivery and efficacy of this gene therapy.
Related Concept Videos
Gene Therapy
Gene Therapy
In-vitro Mutagenesis
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

